This prospective observational study will evaluate postoperative hearing changes in women undergoing elective cesarean delivery under spinal anesthesia. Pure-tone audiometry will be performed before spinal anesthesia and at the predefined postoperative assessment time. The incidence, onset time, and severity of post-dural puncture headache (PDPH) will also be assessed. The study aims to determine whether hearing threshold changes occur after spinal anesthesia and whether these changes are associated with PDPH.
Eligibility
Sex
FEMALE
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* • Women aged 18 years or older.
* Scheduled for elective cesarean delivery.
* Planned spinal anesthesia.
* ASA physical status I-II \[revise if another ASA range is approved in the protocol\].
* Ability to complete preoperative and postoperative pure-tone audiometry assessments.
* Provision of written informed consent.
Exclusion Criteria:
* • Pre-existing hearing loss, use of hearing aids, or inability to complete audiometric testing.
* History of chronic otologic disease, ear surgery, or active ear infection.
* Contraindication to spinal anesthesia.
* Conversion to general anesthesia before completion of the protocol assessments.
* Refusal to participate or withdrawal of consent.
* \[Add any protocol-specific exclusions approved by the ethics committee, such as chronic headache disorder, hypertensive disease of pregnancy, or major perioperative hemorrhage, only if applicable.
Primary outcome measure(s)
Change in Pure-Tone Audiometry Hearing Thresholds After Spinal Anesthesia — : Baseline preoperative assessment to postoperative audiometric assessment at 48 hours after spinal anesthesia The primary outcome is the difference between preoperative and postoperative pure-tone audiometry thresholds at the tested frequencies in each ear. Hearing thresholds will be recorded in decibels hearing level (dB HL), and the change from baseline will be analyzed
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.